Cargando…
The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review
INTRODUCTION: Alcohol use disorder (AUD) is the most prevalent substance use disorder (SUD) globally. In 2019, AUD affected 14.5 million Americans and contributed to 95,000 deaths, with an annual cost exceeding 250 billion dollars. Current treatment options for AUD have moderate therapeutic effects...
Autores principales: | Goldfine, Charlotte E., Tom, Jeremiah J., Im, Dana D., Yudkoff, Benjamin, Anand, Amit, Taylor, Joseph J., Chai, Peter R., Suzuki, Joji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172666/ https://www.ncbi.nlm.nih.gov/pubmed/37181899 http://dx.doi.org/10.3389/fpsyt.2023.1141836 |
Ejemplares similares
-
Novel paradigms for the gut–brain axis during alcohol withdrawal, withdrawal-associated depression, and craving in patients with alcohol use disorder
por: Vatsalya, Vatsalya, et al.
Publicado: (2023) -
Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies
por: Unlu, Hayrunnisa, et al.
Publicado: (2023) -
Ketamine Treatment for Alcohol Use Disorder: A Systematic Review
por: Kelson, Michael, et al.
Publicado: (2023) -
Baclofen and the Alcohol Withdrawal Syndrome-A Short Review
por: Cooney, Gary, et al.
Publicado: (2019) -
Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Protracted Alcohol Withdrawal Symptoms in Male Alcohol-Dependent Patients
por: Wang, Yong-Mei, et al.
Publicado: (2021)